{"id":"W3185598664","doi":"10.1016/j.leukres.2021.106674","title":"Clinical outcome of chronic myeloid leukemia patients who switch from first-line therapy with a second generation tyrosine kinase inhibitor to an alternative TKI","year":2021,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"ca_institutions":"Alberta Cancer Foundation; Alberta Children's Hospital","funders":"Alberta Health Services","keywords":"Medicine; Tyrosine-kinase inhibitor; Myeloid leukemia; Internal medicine; Tyrosine kinase; Nilotinib; Oncology; First line; Dasatinib; Cancer; Imatinib; Receptor","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00118636,0.0005174638,0.00118372,0.0003838461,0.0002675202,0.000100903,0.0004533487,0.0004062868,0.001539184],"category_scores_gemma":[0.000713217,0.0004154134,0.0002292042,0.001153928,0.000327443,0.0003359638,0.0003514383,0.00140674,0.0001840394],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01293652,"about_ca_system_score_gemma":0.006728684,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002908314,"about_ca_topic_score_gemma":0.006814074,"domain_scores_codex":[0.993415,0.0006541418,0.001354505,0.001500002,0.002076953,0.0009993932],"domain_scores_gemma":[0.9945067,0.0006427206,0.0002784869,0.001718788,0.002002926,0.0008504069],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009298584,0.004974024,0.7539639,0.0005500864,0.001702075,0.001749185,0.003177714,0.001235077,0.07800254,0.0002089051,0.01112634,0.1340116],"study_design_scores_gemma":[0.06525271,0.01968886,0.4587885,0.001237686,0.0001880293,0.0000461642,0.0002899306,0.01593257,0.4165491,0.0001883435,0.02082027,0.001017857],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951859,0.0008655479,0.0001843378,0.0006227174,0.0003674119,0.001827758,0.0002796413,0.00006304417,0.0006036774],"genre_scores_gemma":[0.9889224,0.0006957546,0.002258896,0.0005922019,0.00232816,0.0002442361,0.001409891,0.0001440227,0.003404452],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3385465,"threshold_uncertainty_score":0.9998298,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1073731598463201,"score_gpt":0.4001361582505895,"score_spread":0.2927629984042693,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}